Press Releases

GlobeNewswire, Inc.

Q2 2026 revenue of $29.1 million; GAAP basic EPS: $(0.12) Full year 2026 revenue guidance of $100.5 to $111.0 million affirmed NDA for F351 (hydronidone) for CHB-induced liver fibrosis accepted by China’s CDE in May 2026 SAN DIEGO, Aug. 07, 2026...

GlobeNewswire, Inc.

MONTRÉAL, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Saputo Inc. (TSX: SAP) (we, Saputo or the Company) reported today its financial results for the first quarter of fiscal 2027, which ended on June 30, 2026. All amounts in this news release are in...

GlobeNewswire, Inc.

LONG BEACH, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (NASDAQ: SKIN) (“SkinHealth Systems” or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the second quarter ended June 30, 2026...

GlobeNewswire, Inc.

– Operating expenses decline 16%, helping drive a 39% improvement in net loss – – Approximately $3.1 million of TULSA revenue recognition shifts into early Q3 due to shipment timing – – Strong clinical, commercial and reimbursement momentum...

GlobeNewswire, Inc.

Steady revenue growth and adjusted EBITDA margin* expansion Three consecutive quarters of double-digit software Annual Recurring Revenue* (“ARR”) growth TORONTO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Altus Group Limited (ʺAltus Group”, “Altus” or “the...

GlobeNewswire, Inc.

- Duchenne (SGT-003): SGT-003 has been generally well tolerated in the Phase 1/2 INSPIRE DUCHENNE clinical trial, with 53 participants dosed as of August 4, 2026 - - Solid expects to meet with the FDA in late Q4 2026 to discuss the SGT-003 data...

GlobeNewswire, Inc.

Company pivot to neuro-ophthalmology continues with Privosegtor positioned as lead late-stage asset through the registrational PIONEER program with expansion potential in acute multiple sclerosis (MS) relapses following positive FDA pre-IND...

GlobeNewswire, Inc.

Advancing the Alector Brain Carrier (ABC) blood-brain barrier platform across antibodies, enzymes, and siRNA, with AL137 advancing as Alector’s lead ABC-enabled anti-amyloid beta (Aβ) antibody program for Alzheimer’s disease (AD). Continued...

GlobeNewswire, Inc.

New York, NY , Aug. 06, 2026 (GLOBE NEWSWIRE) -- Executive Summary AusWin has unveiled its innovative interactive digital games platform, expanding entertainment options for players throughout Australia.

GlobeNewswire, Inc.

DENVER, Aug. 06, 2026 (GLOBE NEWSWIRE) -- (https://247mnn.com/) – ClearOne (NASDAQ: CLRO), NeOnc Technologies (NASDAQ: NTHI), Iovance Biotherapeutics (NASDAQ:IOVA), and Ensysce Biosciences (NASDAQ:ENSC) are covered in today’s roundup.

EIN Presswire

AI in Fintech Market is growing with AI-powered fraud detection, risk analysis, customer service, personalized banking, and automation.

GlobeNewswire, Inc.

Immunocore reports second quarter financial results and provides a business update KIMMTRAK® (tebentafusp-tebn) net revenues of $115.9 million in Q2 2026, growing by 18% year-over-year Enrollment in Phase 3 TEBE-AM trial for previously treated...

GlobeNewswire, Inc.

Enrollment complete in Phase 3 SONATA-HCM study; top-line data expected Q1 2027 NDA resubmission activities for ZYNQUISTA® in type 1 diabetes nearing completion Phase 1 clinical development of LX9851 ongoing by Novo Nordisk Conference call and...

GlobeNewswire, Inc.

Over 60 clinical sites activated in registrational SAFEGUARD study of SAB-142 in Stage 3 new onset type 1 diabetes; Enrollment remains on track for completion in Q4 2026, with topline data expected in 2H 2027 Breakthrough T1D awarded a grant to...

GlobeNewswire, Inc.

AUSTIN, Texas, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Commerce.com, Inc. (Nasdaq: CMRC), a data-centric provider of an open, AI-driven commerce ecosystem that enables businesses to unlock data, power intelligent discovery and deliver personalized...

GlobeNewswire, Inc.

PreciSION CF Phase 2a proof-of-concept trial evaluating NBD1 stabilizer SION-719 as an add-on to standard of care is on track for topline data summer of 2026 Phase 1 trial evaluating NBD1 stabilizer SION-451 in proprietary dual combinations with...

GlobeNewswire, Inc.

Q2 2026 Revenue, GM and EPS All Exceeded the Guidance Issued on May 7, 2026 Company Q3 2026 Guidance: Revenues to Increase 7% to 11% QoQ, Gross Margin is Expected to be around 34%. Profit per Diluted ADS to be 8.0 Cents to 10.0 Cents Q2 2026...

EIN Presswire

Initiative unites leading tech vendors, giving channel partners a proven framework to modernise organisations for the AI era. SYDNEY, NSW, AUSTRALIA, August 6, 2026 /⁨EINPresswire.com⁩/ -- Ingram Micro today announced expansive support for...

GlobeNewswire, Inc.

First Quarter Financial Highlights: Increased Revenue by 30% Year-over-Year to a Record Level Exceeding $90 Million Reported Record Total Orders Above $130 Million Driven by the Utility-Sector Mining Developments Nearly Quadrupled Operating Cash...

GlobeNewswire, Inc.

Dorel Juvenile reports solid second quarter results supported by international market strength Dorel Home further reduces overhead structure focusing on the profitable Cosco division MONTRÉAL, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Dorel Industries...